State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortium.
Pierluigi CietSilvia BertoloMirco RosRosaria CasciaroMarco CipolliStefano ColagrandeStefano CostaValeria GaliciAndrea GramegnaCecilia LanzaFrancesca LuccaLetizia MacconiFabio MajoAntonella PaciaroniGiuseppe Fabio ParisiFrancesca RizzoIgnazio SalamoneTeresa SantangeloLuigia ScudellerLuca SabaPaolo TomaGiovanni MoranaPublished in: European respiratory review : an official journal of the European Respiratory Society (2022)
There is a need for international guidelines regarding the appropriate timing and selection of imaging modality for patients with CF lung disease; timing and selection depends upon the clinical scenario, the patient's age, lung function and type of treatment. Despite its ubiquity, the use of the chest radiograph remains controversial. Both computed tomography and magnetic resonance imaging should be routinely used to monitor CF lung disease. Future studies should focus on imaging protocol harmonisation both for computed tomography and for magnetic resonance imaging. The introduction of artificial intelligence imaging analysis may further revolutionise clinical practice by providing fast and reliable quantitative outcomes to assess disease status. To date, there is no evidence supporting the use of lung ultrasound to monitor CF lung disease.
Keyphrases
- cystic fibrosis
- magnetic resonance imaging
- lung function
- computed tomography
- high resolution
- artificial intelligence
- clinical practice
- pseudomonas aeruginosa
- machine learning
- big data
- randomized controlled trial
- positron emission tomography
- contrast enhanced
- chronic obstructive pulmonary disease
- air pollution
- mass spectrometry
- fluorescence imaging
- adipose tissue
- case report
- skeletal muscle
- insulin resistance
- weight loss
- photodynamic therapy
- diffusion weighted imaging
- case control